Joe Lennerz, MD, PhD, Chief Scientific Officer to Present on Machine-Driven Genomics and High-Complexity Testing for Transforming Precision Oncology BostonGene ... authors to report on investments ...
January 22, 2025--(BUSINESS WIRE)--BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, announced its participation in The Festival of Genomics & Biodata 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback